Interferon-gamma expression is an independent prognostic factor in ovarian cancer - PubMed (original) (raw)
Interferon-gamma expression is an independent prognostic factor in ovarian cancer
Christian Marth et al. Am J Obstet Gynecol. 2004 Nov.
Abstract
Background: Epithelial ovarian cancer prognosis is improved by the presence of intratumoral CD3 + T cells, which are known to produce interferon-gamma. We therefore speculated that interferon-gamma expression in ovarian cancer-infiltrating T-lymphocytes might cause better prognosis.
Patients and methods: Reverse transcriptase polymerase chain reaction was performed to measure the expression of interferon-gamma and other related genes in normal ovaries (n = 19) and in ovarian cancer specimens (n = 99). Median follow-up of patients was 5.8 years.
Results: Interferon-gamma and CD-3 expression did not significantly differ in normal and malignant tissue. Patients with high levels of interferon-gamma expression had significantly longer progression-free and overall survival. Median time to progression was 10 and 29 months for patients with low and high interferon-gamma expression, respectively ( P = .039). Corresponding survival times were 29 and 44 months ( P < .032). Application of multivariate Cox regression analysis showed interferon-gamma expression to be an independent prognostic factor for progression-free and overall survival.
Conclusion: Elevated interferon-gamma expression correlates with improved clinical outcome in patients with ovarian cancer.
Similar articles
- Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
Kusuda T, Shigemasa K, Arihiro K, Fujii T, Nagai N, Ohama K. Kusuda T, et al. Oncol Rep. 2005 Jun;13(6):1153-8. Oncol Rep. 2005. PMID: 15870936 - Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
Davidson B, Hadar R, Stavnes HT, Trope' CG, Reich R. Davidson B, et al. Hum Pathol. 2009 May;40(5):705-13. doi: 10.1016/j.humpath.2008.09.019. Epub 2009 Jan 20. Hum Pathol. 2009. PMID: 19157507 - Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum.
Paju A, Vartiainen J, Haglund C, Itkonen O, von Boguslawski K, Leminen A, Wahlström T, Stenman UH. Paju A, et al. Clin Cancer Res. 2004 Jul 15;10(14):4761-8. doi: 10.1158/1078-0432.CCR-0204-03. Clin Cancer Res. 2004. PMID: 15269150 - Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
Bamias A, Koutsoukou V, Terpos E, Tsiatas ML, Liakos C, Tsitsilonis O, Rodolakis A, Voulgaris Z, Vlahos G, Papageorgiou T, Papatheodoridis G, Archimandritis A, Antsaklis A, Dimopoulos MA. Bamias A, et al. Gynecol Oncol. 2008 Feb;108(2):421-7. doi: 10.1016/j.ygyno.2007.10.018. Epub 2007 Nov 26. Gynecol Oncol. 2008. PMID: 18036640 - Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
Lu L, Katsaros D, Wiley A, de la Longrais IA, Puopolo M, Yu H. Lu L, et al. Cancer Invest. 2008 Mar;26(2):185-92. doi: 10.1080/07357900701638343. Cancer Invest. 2008. PMID: 18259951
Cited by
- IFNγ-Induced Bcl3, PD-L1 and IL-8 Signaling in Ovarian Cancer: Mechanisms and Clinical Significance.
Reddy SU, Sadia FZ, Vancura A, Vancurova I. Reddy SU, et al. Cancers (Basel). 2024 Jul 27;16(15):2676. doi: 10.3390/cancers16152676. Cancers (Basel). 2024. PMID: 39123403 Free PMC article. Review. - Similar immune responses to alpha1-oleate and Bacillus Calmette-Guérin treatment in patients with bladder cancer.
Ahmadi S, Ambite I, Brisuda A, Háček J, Haq F, Sabari S, Vanarsa K, Mohan C, Babjuk M, Svanborg C. Ahmadi S, et al. Cancer Med. 2024 Apr;13(7):e7091. doi: 10.1002/cam4.7091. Cancer Med. 2024. PMID: 38553868 Free PMC article. - Immunological Study of IFN-γ, ICAM-4, and Vitamin D3 Markers among Gastrointestinal Tumor Patients in Babylon Province, Iraq.
Al-Shimmery AHS, Mahdi ZA, Al-Hindy HAM, Al-Mammori RTO, Mokif TA, Al-Dahmoshi HOM, Al-Khafaji NSK. Al-Shimmery AHS, et al. Asian Pac J Cancer Prev. 2023 Jan 1;24(1):301-305. doi: 10.31557/APJCP.2023.24.1.301. Asian Pac J Cancer Prev. 2023. PMID: 36708580 Free PMC article. - Multi-omics-based analysis of high grade serous ovarian cancer subtypes reveals distinct molecular processes linked to patient prognosis.
Wang YA, Neff R, Song WM, Zhou X, Vatansever S, Walsh MJ, Chen SH, Zhang B. Wang YA, et al. FEBS Open Bio. 2023 Apr;13(4):617-637. doi: 10.1002/2211-5463.13553. Epub 2023 Feb 24. FEBS Open Bio. 2023. PMID: 36637997 Free PMC article. - The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis.
Lin K, Baritaki S, Vivarelli S, Falzone L, Scalisi A, Libra M, Bonavida B. Lin K, et al. Antioxidants (Basel). 2022 Jun 17;11(6):1195. doi: 10.3390/antiox11061195. Antioxidants (Basel). 2022. PMID: 35740092 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical